# Correction: Kammoun et al. Etodolac Fortified Sodium Deoxycholate Stabilized Zein Nanoplatforms for Augmented Repositioning Profile in Human Hepatocellular Carcinoma: Assessment of Bioaccessibility, Anti-Proliferation, Pro-Apoptosis and Oxidant Potentials in HepG2 Cells. Pharmaceuticals 2022, 15, 916

**Authors:** Ahmed K. Kammoun, Maha A. Hegazy, Alaa Khedr, Zuhier Ahmed Awan, Maan T. Khayat, Majid Mohammad Al-Sawahli

PMC · DOI: 10.3390/ph18040505 · Pharmaceuticals · 2025-03-31

## Full-text entities

- **Diseases:** Hepatocellular Carcinoma (MESH:D006528)
- **Chemicals:** Etodolac (MESH:D017308), Sodium Deoxycholate (MESH:D003840)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12030595/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12030595/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12030595/full.md

---
Source: https://tomesphere.com/paper/PMC12030595